Skip to main content

Our Science

For more than 50 years, we've been innovating to bring you the latest in healthcare advancements. Explore posters, publications and upcoming webinars or conferences.

Recent Peer Reviewed Manuscripts and Conference Posters

Posters  —  4 March Mar 2025
Oncology

Inhalation rat tube restraint – Best practice guidance

Read More about Inhalation rat tube restraint – Best practice guidance
Posters  —  4 March Mar 2025
Oncology

Continuous infusion in minipigs via semi-permanent over-the-wire central venous catheters using OrchesTA infusion pumps

Read More about Continuous infusion in minipigs via semi-permanent over-the-wire central venous catheters using OrchesTA infusion pumps
Posters  —  4 March Mar 2025
Oncology

Rabbit exercising program in a laboratory environment

Read More about Rabbit exercising program in a laboratory environment
Posters  —  4 March Mar 2025
Oncology

Positive reinforcement training: Old-World NHPs

Read More about Positive reinforcement training: Old-World NHPs
Posters  —  4 March Mar 2025
Oncology

The progression on welfare for rat pain response

Read More about The progression on welfare for rat pain response
Posters  —  4 March Mar 2025
Oncology

Dog group feeding: A refinement rooted in the 3Rs

Read More about Dog group feeding: A refinement rooted in the 3Rs
Posters  —  4 March Mar 2025
Oncology

Continuous intravenous infusion in mice to support drug development: An update to include juvenile testing

Read More about Continuous intravenous infusion in mice to support drug development: An update to include juvenile testing
Posters  —  4 March Mar 2025
Oncology

The use of body condition scoring - Old-World nonhuman primates

Read More about The use of body condition scoring - Old-World nonhuman primates
Posters  —  4 March Mar 2025
Oncology

Test or enrichment?

Read More about Test or enrichment?
Posters  —  27 November Nov 2024
Oncology

Biologic drug and anti-drug antibody monitoring: TNF inhibitors infliximab, adalimumab and certolizumab pegol in 128,537 patient samples

Read More about Biologic drug and anti-drug antibody monitoring: TNF inhibitors infliximab, adalimumab and certolizumab pegol in 128,537 patient samples
Posters  —  27 November Nov 2024
Oncology

New blood-based test, 7 alpha-hydroxy-4-cholesten-3-one (7AlphaC4), for bile acid malabsorption/bile acid diarrhea in inflammatory bowel disease or unspecified diarrhea

Read More about New blood-based test, 7 alpha-hydroxy-4-cholesten-3-one (7AlphaC4), for bile acid malabsorption/bile acid diarrhea in inflammatory bowel disease or unspecified diarrhea
Posters  —  27 November Nov 2024
Oncology

Unmasking Crohn’s Disease: Anti-glycan antibodies (ACCA, ALCA, AMCA) may improve diagnostic accuracy while providing prognostic value, especially in ASCA-seronegative patients

Read More about Unmasking Crohn’s Disease: Anti-glycan antibodies (ACCA, ALCA, AMCA) may improve diagnostic accuracy while providing prognostic value, especially in ASCA-seronegative patients
Posters  —  23 November Nov 2024
Oncology

Analytical validation of OmniSeq® INSIGHT whole transcriptome sequencing assay to facilitate precision oncology through tumoronly testing in solid tumors

Read More about Analytical validation of OmniSeq® INSIGHT whole transcriptome sequencing assay to facilitate precision oncology through tumoronly testing in solid tumors
Posters  —  23 November Nov 2024
Oncology

Analytical validation of OmniSeq® INSIGHT whole exome sequencing assay to facilitate precision oncology through tumor only testing in solid tumors

Read More about Analytical validation of OmniSeq® INSIGHT whole exome sequencing assay to facilitate precision oncology through tumor only testing in solid tumors
Posters  —  23 November Nov 2024
Oncology

Validation of automated nucleic acid extraction using Covaris® Gen3 extraction methodology on the Assay-Ready Workstation

Read More about Validation of automated nucleic acid extraction using Covaris® Gen3 extraction methodology on the Assay-Ready Workstation

Upcoming Conferences

Upcoming and Recent Webinars

Webinars  —  18 December Dec 2024
Oncology

Operationalizing Innovative Biomarkers to Support Evolving Therapeutic and Diagnostic Landscape for Neurodegenerative Diseases

Read More about Operationalizing Innovative Biomarkers to Support Evolving Therapeutic and Diagnostic Landscape for Neurodegenerative Diseases
Webinars  —  17 December Dec 2024
Oncology

On-demand webinar: Developing predictive cancer models and more persistent CAR T-cell therapies through enhanced metabolic fitness

Read More about On-demand webinar: Developing predictive cancer models and more persistent CAR T-cell therapies through enhanced metabolic fitness
Webinars  —  6 December Dec 2024
Oncology

Molecular Tumor Board: 82-year-old female with high grade ovarian serous adenocarcinoma and BRCA1 F709fs mutation

Read More about Molecular Tumor Board: 82-year-old female with high grade ovarian serous adenocarcinoma and BRCA1 F709fs mutation
Webinars  —  23 October Oct 2024
Oncology

Clinical considerations of drug testing in the primary care setting

Read More about Clinical considerations of drug testing in the primary care setting

Scientific Experts

Aaron Ledvina, PhD

 Senior Scientific Support Specialist, LC-MS Bioanalytical Services

Adam Schechter

 Chairman, President, and Chief Executive Officer

Agnes Zybura, PhD

 Scientist, Molecular Bioanalysis

Ajay Grover, PhD

 Co-Discipline Director, Immunology, Flow Cytometry and Infectious Disease Immunology, Labcorp

Alan Lackey

 Associate Director, Flow Cytometry Validations

Alex Katayev, MD

 Associate Vice President and Director of Clinical Science Assessment; Discipline Director, Quality Control, Labcorp

Alexandre Fort, PhD

 Lead Scientist, Genomics

Alicia Carter, MD

 Vice President; Discipline Director, Anatomic Pathology and Histology/Cytology, Labcorp

Allan Watkinson, PhD

 Director, Scientific Affairs GMP

Amanda Wilson

 Global Director of Method Development & Validation, LC-MS Bioanalytical Services Labcorp

Amy Summy

 Executive Vice President and Chief Marketing Officer

Anas Tomeh, PhD

 Research and Development Scientist

Andrea Throop, PhD

 Discipline Director, Routine Chemistry, Phoenix Regional Laboratory

André Valcour, PhD, MBA, DABCC

 Vice President and Laboratory Director, Center for Esoteric Testing, Labcorp; Discipline Director of Allergy, Coagulation, and Endocrinology, Labcorp

Anissa Fries, PhD

 Staff Scientist, Flow Cytometry

Anita Graham

 EVP and Chief Human Resources Officer

Anjen Chenn, MD, PhD

 Medical and Scientific Director, Discipline Director, Molecular Oncology, Labcorp

Anthony Guihur, PhD

 Staff Scientist II, Genomics

Araceli B. Reyes, MD

 Divisional Medical Director, Northeast Division, Labcorp

Aradhana Ghosh, MD

 VP, Oncology Informatics